Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Soybean plants grow in a farm field outside Tiskilwa, Illinois, U.S., on Tuesday, July 2, 2019. President Donald Trumps $16 billion in additional trade-war aid for farmers appears to be paying off, as optimism rebounds in a key political constituency for his 2020 re-election bid. A gauge of agricultural sentiment sharply rebounded in June after a darkening mood on Americas farms throughout the spring amid a damaging trade war with China and relentless rain that restricted planting. Photographer: Daniel Acker/Bloomberg Soybean plants grow in a farm field outside Tiskilwa, Illinois, on July 2, 2019. Photo: Daniel Acker/Bloomberg

This month’s $265 million verdict over Monsanto Co.’s dicamba herbicide sprouted more legal trouble for the agricultural giant, which is appealing nearly $2.4 billion in Roundup verdicts, but the cases are far afield from one another in the allegations they raise.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]

Amanda Bronstad

Amanda Bronstad is the ALM staff reporter covering class actions and mass torts nationwide. She writes the email dispatch Critical Mass. She is based in Los Angeles.

More from this author


Drug and Medical Device Product Liability DeskbookBook

This timely guide covers all aspects of litigation involving drugs, medical devices, vaccines and other FDA-regulated prescription products.

Get More Information

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.